Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 21 for “"Cytoreduction"”.

  1. A population-level evaluation of barriers and facilitators to referral in Cytoreduction/Hyperthermic Intraperitoneal Chemotherapy using knowledge translation methodology.

    Introduction: Referral for CS/HIPEC is variable, and barriers encountered by referring physicians are unknown. Identification of such barriers is useful for the creation of tailored knowledge translation (KT) strategies. Methods: Interviews of 20 medical oncologists and surgeons in the New York …

    mcmaster Repository record for A population-level evaluation of barriers and facilitators to referral in Cytoreduction/Hyperthermic Intraperitoneal Chemotherapy using knowledge translation methodology. (opens in a new tab)

  2. BRCA1/2 mutation spectrum and its prognostic significance for progression-free and overall survival in advanced ovarian cancer /

    … most frequent. It amounted to 63.6%. Non-optimal cytoreduction (p<0,0001 ) , patients’ older age (p=0,005) and absence of BRCA1/2 mutations (p=0,049) are closely connected with a shorter PFS and OS. Only non-optimal cytoreduction was related to a shorter OS (p=0,010).

    vilnius Repository record for BRCA1/2 mutation spectrum and its prognostic significance for progression-free and overall survival in advanced ovarian cancer / (opens in a new tab)

  3. Išplitusio kiaušidžių vėžio BRCA1/2 genų mutacijų įvairovė ir jų prognozinė reikšmė ligos berecidyviam ir bendrajam pacienčių išgyvenamumui /

    … most frequent. It amounted to 63.6%. Non-optimal cytoreduction (p<0,0001 ) , patients’ older age (p=0,005) and absence of BRCA1/2 mutations (p=0,049) are closely connected with a shorter PFS and OS. Only non-optimal cytoreduction was related to a shorter OS (p=0,010).

    vilnius Repository record for Išplitusio kiaušidžių vėžio BRCA1/2 genų mutacijų įvairovė ir jų prognozinė reikšmė ligos berecidyviam ir bendrajam pacienčių išgyvenamumui / (opens in a new tab)

  4. Effects of the implantation of intra-abdominal protheses in a mouse model of ovarian peritoneal carcinosis

    … mesh implantation following resection and/or cytoreduction. Using the murine model of ovarian-type peritoneal cancer (PC) which is induced by intraperitoneal injection of ID8 – Luc ovarian cancer cells in immunocompetent C57BL/6 mice in the presence or the absence of intraabdominal prostheses …

    liege Repository record for Effects of the implantation of intra-abdominal protheses in a mouse model of ovarian peritoneal carcinosis (opens in a new tab)

  5. Η επίδραση της ενδοπεριτοναϊκής έγχυσης της ρεγοραφενίμπης στην περιτοναϊκή διασπορά του καρκίνου του παχέος εντέρου μετά κυτταρομείωση σε επίμυες

    … with a very poor prognosis and quality of life. Cytoreduction combined with intraperitoneal chemotherapy is the most effective treatment strategy in selected patients with resectable colorectal cancer and peritoneal dissemination. Regorafenib is an orally administered, pleiotropic, …

    greece Repository record for Η επίδραση της ενδοπεριτοναϊκής έγχυσης της ρεγοραφενίμπης στην περιτοναϊκή διασπορά του καρκίνου του παχέος εντέρου μετά κυτταρομείωση σε επίμυες (opens in a new tab)

  6. Role of the operative tumor reduction in patients with epithelial ovarian cancer and suboptimal tumor debulking

    … to gynaecologic cancer worldwide. Surgical cytoreduction is the cornerstone of current treatment in patients with advanced primary disease. In contrast, the value of surgery in recurrent ovarian cancer (ROC) remains unclear. In the present study, we evaluate the role of postoperative tumor …

    fu-berlin Repository record for Role of the operative tumor reduction in patients with epithelial ovarian cancer and suboptimal tumor debulking (opens in a new tab)

  7. Ο ρόλος των βλαστοκυττάρων στα Γλοιώματα

    … όσον αφορά στη μείωση του όγκου των γλοιωμάτων (cytoreduction), αλλά και στη χορήγηση φαρμάκων. Ευτυχώς, η εξέλιξη της τεχνολογίας και της μοριακής βιολογίας δίνει την δυνατότητα στους ερευνητές να εξηγήσουν τα πρώτα βήματα σχηματισμού των γλοιωμάτων και να συγκεντρώσουν γνώσεις σχετικά με τα …

    athens Repository record for Ο ρόλος των βλαστοκυττάρων στα Γλοιώματα (opens in a new tab)

  8. The psychological impact and clinical outcomes associated with testing for ovarian cancer in symptomatic women

    … (performance status, stage at diagnosis, cytoreduction rate, extent of disease) in women diagnosed with high grade serous OC, the most lethal form of OC was evaluated. Results: Findings from our SR demonstrated that the contribution of some factors to anxiety in cancer testing and their …

    birmingham Download PDF for The psychological impact and clinical outcomes associated with testing for ovarian cancer in symptomatic women (opens in a new tab)

  9. Novel cell intrinsic factors in the pathogenesis of JAK2 V617F positive myeloproliferative neoplasms

    … effectively managed by antiplatelet therapy and cytoreduction for selected patients at highest risk. Prognosis is hugely variable and is dependent on multiple factors including disease phenotype, driver mutation status, the presence of additional pathogenic mutations, epigenetic dysregulation and …

    qu-belfast Repository record for Novel cell intrinsic factors in the pathogenesis of JAK2 V617F positive myeloproliferative neoplasms (opens in a new tab) Download PDF for Novel cell intrinsic factors in the pathogenesis of JAK2 V617F positive myeloproliferative neoplasms (opens in a new tab)

  10. Elucidation of a novel mechanism of peritoneal dissemination and platinum resistance of ovarian cancer by tumor-associated fibrosis (TAF) 〜Cancer, Fibrosis and Women's Health Care〜

    … of peritoneal-specific relapse despite complete cytoreduction. A separate analysis of normal human ovaries indicated an agedependent increase in stromal fibrosis, suggesting a biological continuum between aging and tumor-favorable stromal changes. In summary, our findings identify TAF as a key …

    adelaide Repository record for Elucidation of a novel mechanism of peritoneal dissemination and platinum resistance of ovarian cancer by tumor-associated fibrosis (TAF) 〜Cancer, Fibrosis and Women's Health Care〜 (opens in a new tab)

  11. Ergebnisse der zytoreduktiven Chirurgie und hyperthermen intraperitonealen Chemotherapie in der Behandlung des peritoneal metastasierten Magenkarzinoms

    … Tumorlast wurde über den Completeness of Cytoreduction Score (CC-Score) ermittelt. Die Klassifikation der postoperativen Mortalität erfolgte nach Clavien-Dindo und die Schätzung der Überlebenszeiten nach Kaplan-Meier. Die statistische Aufarbeitung des Datensatzes erfolgte mit IBM …

    fu-berlin Repository record for Ergebnisse der zytoreduktiven Chirurgie und hyperthermen intraperitonealen Chemotherapie in der Behandlung des peritoneal metastasierten Magenkarzinoms (opens in a new tab)

  12. Analysis of essential thrombocythemia and its treatment

    … Common treatment approaches seek to use cytoreduction and platelet inhibition to lower the risk of a thrombotic event. Hydroxyurea and low-dose aspirin have been the gold-standard of treatment for ET patients. This thesis sought to compare the current available therapy with second-line …

    bu Repository record for Analysis of essential thrombocythemia and its treatment (opens in a new tab)

  13. Η χειρουργική αντιμετώπιση του ψευδομυξώματος του περιτοναίου

    … περιτοναικής κοιλότητας. Το CCS (completeness of cytoreduction score) είναι το τελικό εργαλείο της διεγχειρητικής αξιολόγησης της πρόγνωσης με βάση την πληρότητα της κυτταρομείωσης. Η σχετιζόμενη με την τεχνική, νοσηρότητα είναι σοβαρή, ειδικά στην περίπτωση εκτεταμένων εξαιρέσεων. Ο κίνδυνος …

    athens Repository record for Η χειρουργική αντιμετώπιση του ψευδομυξώματος του περιτοναίου (opens in a new tab)

  14. Is there a place for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the treatment of pancreatic adenocarcinoma? A systematic review.

    … A terms: “CRS” OR “cytoreductive surgery” OR “cytoreduction” OR “Hipec” OR “Hyperthermic Intraperitoneal Chemotherapy”. Group B terms: “pancreas” OR “pancreatic”. Χρησιμοποιήθηκαν επιπλέον φίλτρα για τον περιορισμό σε εργασίες που αφορούσαν ανθρώπους, ήταν στην Αγγλική γλώσσα και είχαν …

    athens Repository record for Is there a place for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the treatment of pancreatic adenocarcinoma? A systematic review. (opens in a new tab)

  15. Determining the effect of double-stranded RNA treatment in ovarian cancer

    … Standard treatment protocol involves surgical cytoreduction, followed by a combination of taxane and platinum-based chemotherapeutics. Initially this treatment is successful however, most patients face recurring tumors that over time become resistant to current drug regimens. Thus, novel …

    vcu Repository record for Determining the effect of double-stranded RNA treatment in ovarian cancer (opens in a new tab)

  16. Μελέτη υποπληθυσμών των λεμφοκυττάρων των όγκων σε καρκίνο ωοθηκών: συσχέτιση με την παραγωγή κυτταροκινών και διερεύνηση της προγνωστικής τους σημασίας

    … III and IV). Current treatment includes surgical cytoreduction and post-surgery platinum–paclitaxel chemotherapy. Despite the initial response to treatment, relapse (and death from the disease) will still occur in 70% of patients. Established prognostic factors for EOC include stage, volume of …

    greece Repository record for Μελέτη υποπληθυσμών των λεμφοκυττάρων των όγκων σε καρκίνο ωοθηκών: συσχέτιση με την παραγωγή κυτταροκινών και διερεύνηση της προγνωστικής τους σημασίας (opens in a new tab)

  17. Immunhistochemische Untersuchungen zur Expression von Tumormarkern und Wachstumsfaktorrezeptoren bei Hunden mit malignen Nasentumoren

    Einleitung: Nasenhöhlentumoren stellen mit bis zu 47 % die Hauptursache für Nasenausfluss beim Hund dar. Sie sind überwiegend maligne, zu 60 % Karzinome und zu 34 % Sarkome. Die mediane Überlebenszeit (MÜZ) liegt ohne Therapie bei etwa drei Monaten. Nach einer Bestrahlungstherapie beträgt sie etwa …

    qucosa-diss

  18. CT-gesteuerte Hochdosis-Brachytherapie (CT-HDRBT): Ergebnisse der Therapie von Lebertumoren innerhalb und jenseits der Indikationen der Radiofrequenzablation (RFA)

    … nach CT-HDRBT im Sinne einer minimal- invasiven Cytoreduction bei 37 Patientinnen mit 80 nicht resektablen BCLM untersucht. Das durchschnittliche Follow-up nach CT-HDRBT betrug 11,6 Monate. Eine lokale Tumorprogression konnte lediglich in zwei (2,6%) der behandelten Metastasen festgestellt …

    fu-berlin Repository record for CT-gesteuerte Hochdosis-Brachytherapie (CT-HDRBT): Ergebnisse der Therapie von Lebertumoren innerhalb und jenseits der Indikationen der Radiofrequenzablation (RFA) (opens in a new tab)

Page 1 of 2